CA2070647A1 - Use of an anticoagulant as a diagnostic agent - Google Patents

Use of an anticoagulant as a diagnostic agent

Info

Publication number
CA2070647A1
CA2070647A1 CA002070647A CA2070647A CA2070647A1 CA 2070647 A1 CA2070647 A1 CA 2070647A1 CA 002070647 A CA002070647 A CA 002070647A CA 2070647 A CA2070647 A CA 2070647A CA 2070647 A1 CA2070647 A1 CA 2070647A1
Authority
CA
Canada
Prior art keywords
anticoagulant
diagnostic agent
agnostic
labelled
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002070647A
Other languages
French (fr)
Other versions
CA2070647C (en
Inventor
Christiaan Reutelingsperger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6396455&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2070647(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2070647A1 publication Critical patent/CA2070647A1/en
Application granted granted Critical
Publication of CA2070647C publication Critical patent/CA2070647C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/087—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being an annexin, e.g. annexin V
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Dental Preparations (AREA)
  • External Artificial Organs (AREA)

Abstract

The invention relates to agents, in particular annexins, which are labelled with a detectable substance and their use for di-agnostic purposes.
CA002070647A 1989-12-27 1990-12-19 Use of an anticoagulant as a diagnostic agent Expired - Lifetime CA2070647C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP3942988.1 1989-12-27
DE3942988 1989-12-27
PCT/EP1990/002257 WO1991009628A1 (en) 1989-12-27 1990-12-19 Use of an anticoagulant as a diagnostic agent

Publications (2)

Publication Number Publication Date
CA2070647A1 true CA2070647A1 (en) 1991-06-28
CA2070647C CA2070647C (en) 2001-04-10

Family

ID=6396455

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002070647A Expired - Lifetime CA2070647C (en) 1989-12-27 1990-12-19 Use of an anticoagulant as a diagnostic agent

Country Status (15)

Country Link
EP (2) EP0509026B1 (en)
JP (1) JP3135261B2 (en)
KR (1) KR0181520B1 (en)
AT (2) ATE164083T1 (en)
AU (1) AU642202B2 (en)
CA (1) CA2070647C (en)
DE (3) DE4040817A1 (en)
ES (1) ES2113372T3 (en)
FI (1) FI107586B (en)
HU (2) HUT61491A (en)
NO (1) NO305276B1 (en)
NZ (1) NZ236620A (en)
PT (1) PT96385B (en)
WO (1) WO1991009628A1 (en)
ZA (1) ZA9010319B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
DE69331319T2 (en) * 1992-06-09 2002-08-08 Neorx Corp., Seattle Biotin-DOTA conjugates and their use in "pretargeting" processes
WO1995014788A1 (en) * 1993-11-24 1995-06-01 University Of Washington Blood coagulation retardants and devices
EP0743861B1 (en) * 1994-01-24 2003-04-16 Neorx Corporation Radiolabeled annexins
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
EP0763056B1 (en) * 1994-03-16 2000-08-09 Mallinckrodt Inc. Use of surfactants for stabilization of peptides and proteins for radiopharmaceutical use
WO1995027903A1 (en) * 1994-04-11 1995-10-19 Nexins Research B.V. A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
EP0765166B1 (en) * 1994-06-16 2003-05-21 Neorx Corporation Radiolabeled annexin-galactose conjugates
DE69530841T2 (en) * 1994-06-16 2004-05-06 Neorx Corp., Seattle RADIOACTIVELY MARKED ANNEXIN GALACTOSE CONJUGATES
US5886143A (en) * 1994-12-07 1999-03-23 Neorx Corporation Hepatic-directed compounds and reagents for preparation thereof
EP0799050B1 (en) * 1994-12-07 2004-08-11 Neorx Corporation Radiolabeled annexin-galactose cluster conjugates
EP1486509A3 (en) * 1994-12-07 2005-03-23 Neorx Corporation Radiolabeled annexin-galactose cluster conjugates
US5955605A (en) * 1995-02-21 1999-09-21 Neorx Corporation Biotinidase resistant biotin-DOTA conjugates
FR2736197B1 (en) * 1995-06-29 1997-09-12 Univ Paris Curie MAGNETIC NANOPARTICLES COUPLED WITH ANNEXIN AND THEIR USE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427646A (en) * 1981-04-02 1984-01-24 Research Corporation Use of radiolabeled peptide derived from crosslinked fibrin to locate thrombi in vivo
US4455290A (en) * 1981-04-02 1984-06-19 Research Corporation Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1
US4820505A (en) * 1985-04-04 1989-04-11 Scripps Clinic And Research Foundation Detection of activated platelets with antibodies to thrombospondin
PT87083B (en) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int A PROCESS FOR THE PREPARATION OF A VASCULAR ANTICOAGULANT PROTEIN, OF DNA THAT CODIFIES FOR THIS PROTEIN AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING IT
DE3810331A1 (en) * 1988-03-26 1989-10-05 Boehringer Ingelheim Int Monoclonal VAC antibodies

Also Published As

Publication number Publication date
FI107586B (en) 2001-09-14
ATE429644T1 (en) 2009-05-15
JP3135261B2 (en) 2001-02-13
FI922719A0 (en) 1992-06-12
JPH05502877A (en) 1993-05-20
KR920703121A (en) 1992-12-17
NZ236620A (en) 1997-03-24
EP0806670B1 (en) 2009-04-22
NO305276B1 (en) 1999-05-03
AU642202B2 (en) 1993-10-14
EP0509026B1 (en) 1998-03-18
DE59010815D1 (en) 1998-04-23
EP0509026A1 (en) 1992-10-21
DE4040817A1 (en) 1991-07-04
ES2113372T3 (en) 1998-05-01
CA2070647C (en) 2001-04-10
ZA9010319B (en) 1992-08-26
AU7071191A (en) 1991-07-24
NO922528L (en) 1992-08-26
PT96385B (en) 1998-06-30
NO922528D0 (en) 1992-06-26
DE59010946D1 (en) 2009-06-04
EP0806670A3 (en) 1997-12-10
HU209650B (en) 1994-09-28
ATE164083T1 (en) 1998-04-15
PT96385A (en) 1991-10-31
WO1991009628A1 (en) 1991-07-11
KR0181520B1 (en) 1999-05-01
EP0806670A2 (en) 1997-11-12
HUT61491A (en) 1993-01-28
HU9202149D0 (en) 1992-10-28

Similar Documents

Publication Publication Date Title
CA2070647A1 (en) Use of an anticoagulant as a diagnostic agent
SE8000469L (en) TISSUE BINDING AND PROCEDURE FOR ITS MANUFACTURING AND USING THE BINDING AGENT
BR8901723A (en) LIQUID, WATERFUL, HOMOGENE AND CLEANING CLEANING COMPOSITION
FI930601A7 (en) 3,5-substituted benzoylguanidines, a process for their preparation, their use as a medicinal substance or diagnostic substance, and a medicinal substance containing them
DE69014519D1 (en) Ionomer composition.
IL96458A0 (en) Isoxazolines,their preparation,and their use as plantprotecting agents
IT8821134A0 (en) PROCYANIDOL OLIGOMEROUS FRACTIONS, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
CA2071981A1 (en) The use of gaba-b selective agonists as anti-tussive agents
FI942598A7 (en) Substituted benzoylguanidines, a method for their preparation, their use as a medicinal substance or diagnostic substance, and a medicinal substance containing them
IL95394A0 (en) Amide complexes and diagnostic agents containing the same
ES2133285T3 (en) WATER-SOLUBLE POLYPEPTIDES THAT HAVE A HIGH AFFINITY FOR THE ALPHA AND BETA INTERFERONS.
DE69016245D1 (en) Tissue conditioning articles.
DE69007518D1 (en) Polishing composition.
FI902648A0 (en) INTEGRATED MINNE MED EN DETEKTORFOERSTAERKARE.
FI850644A7 (en) In vitro diagnostic procedure and diagnostic agent.
IT1241631B (en) "N, N'-DITRIMETOSSIBENZOILPIPERAZINE 2-REPLACED, PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS CONTAINING THEM
AU8105087A (en) Hemolysis inhibitor and medical resin composition, medical implement, and blood-preserving fluid containing the same
IT8723085A0 (en) PROTECTIVE IMMUNODMINANT EPITOPE CONTAINED IN THE S1 SUBUNITY OF PERTUSES TOXIN.
NO900564D0 (en) SURFACTIVE AGENT.
NO903347D0 (en) PROCEDURE FOR THE PREPARATION OF 14,17ALFA-ETHANO AND ETHANOESTRATRIAGES.
DE69001910D1 (en) FLUID COMPRESSOR.
IT1236969B (en) 3-CYAN-3,5,5'-TRIMETHYL-1-CYCLOHEXANONE PREPARATION PROCEDURE.
NO910039L (en) NON-DAMAGING OVERVIEW AND COMPLETION FLUID.
CA2000153A1 (en) Antidote
AU638082B2 (en) Thiazolyl-5-carbonamide derivatives, the preparation thereof composition containing them and their use against microorganisms

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry